One‐year clinically important deterioration and long‐term clinical course in Japanese patients with COPD: a multicenter observational cohort study
Abstract Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a complex progression of many clinical presentations, and clinically important deterioration (CID) has been proposed in the Western studies as a composite endpoint of disease progression. The aim of this...
Main Authors: | Yuki Abe, Masaru Suzuki, Hironi Makita, Hirokazu Kimura, Kaoruko Shimizu, Satoshi Konno, Masaharu Nishimura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-021-01510-w |
Similar Items
-
Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
by: Mona Bafadhel, et al.
Published: (2020-01-01) -
Measuring disease activity in COPD: is clinically important deterioration the answer?
by: Dave Singh, et al.
Published: (2020-06-01) -
Long-term outcomes following first short-term clinically important deterioration in COPD
by: Ian P. Naya, et al.
Published: (2018-11-01) -
Determination of the cutoff values of Th2 markers for the prediction of future exacerbation in severe asthma: An analysis from the Hokkaido Severe Asthma Cohort Study
by: Hirokazu Kimura, et al.
Published: (2021-01-01) -
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
by: Klaus F. Rabe, et al.
Published: (2020-07-01)